Gene Query: UBXN2B

Dataset Description Geneva Score
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  26.24
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 20.13
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 18.56
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 17.02
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 16.27
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 15.6
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 14.57
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 13.78
Examining serotonergic neuron differentiation from human iPSCs 13.43
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 12.76
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 12.48
hnRNP C is a key regulator of protein synthesis in mitosis 12.29
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 11.85
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 11.73
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 11.73
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 11.56
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 11.45
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 11.11
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 10.88
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 10.88
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 10.7
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 10.17
Altering cancer transcriptomes using epigenomic inhibitors 10.17
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 10.1
Nutritional control of protein translation 9.98
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 9.9
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 9.72
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 9.71
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 9.69
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 9.52
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 9.52
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.48
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 9.45
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 9.29
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 9.23
Seletive inhibition of CDK9 in DLBCL cell lines 9.03
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 8.99
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 8.99
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 8.73
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 8.68
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.55
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.55
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 8.47
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 8.44
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 8.44
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 8.42
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 8.39
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 8.34
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 8.23
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 8.23
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.21
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 8.18
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 8.09
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 7.97
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 7.97
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 7.96
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 7.92
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.87
BI Human Reference Epigenome Mapping Project 7.78
Generation of KRAS signatures using immortalized isogenic lung cells. 7.72
LIN28A modulates splicing and gene expression programs in breast cancer cells 7.69
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 7.69
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 7.55
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.46
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 7.42
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 7.41
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 7.4
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 7.37
Transcriptional profile in human S. haematobium infection 7.31
RNA-seq analysis of uveal melanoma cells treated with FR900359 7.22
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.16
BAF controls genome accessibility 7.14
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 7.13
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.13
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.13
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.13
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 7.1
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 7.1
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 7.05
LncRNA expression profiling of ischemic stroke patients 7.03
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 7.02
Solid phase chemistry to covalently and reversibly capture thiolated RNA 6.93
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 6.9
IDH3a KO RNA-seq 6.88
RNA-Seq with and without RNase treatment in PCa cell lines 6.87
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 6.85
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 6.85
MYC dependent mRNA translation shapes gene expression and cell biology 6.82
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 6.81
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 6.81
RNA-seq of YB5 cells treated with Proscillaridin A 6.77
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.75
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.73
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 6.71
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.68
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 6.65
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 6.61
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 6.6
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 6.59
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.55
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 6.53
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 6.53
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 6.51
A role for ZNF598 in post-transcriptional gene regulation 6.41
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 6.37
Genome-wide chromatin analysis of Ewing sarcoma 6.36
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 6.36
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 6.35
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 6.29
Human cell line and subcutaneous tumor 6.26
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.17
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.14
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 6.1
Effect of PBK knockdown on C4-2 cell transcriptome 6.06
RNA-seq of MCF10A cells and CAF 5.96
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 5.91
A map of gene expression in neutrophil-like cell lines 5.85
RNAseq analysis of ESRP regulated splicing events in prostate cancer 5.84
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 5.81
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 5.72
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 5.71
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 5.69
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 5.69
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 5.67
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 5.66
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 5.66
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.63
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 5.62
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.59
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 5.58
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 5.57
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 5.55
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 5.51
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 5.5
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 5.41
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 5.31
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 5.28
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.27
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 5.19
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.17
Cell responses to dysregulated VZV-induced cell-cell fusion 5.17
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 5.16
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 5.15
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 5.15
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 5.15
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 5.13
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 5.12
Effect of disulfiram treatment on pediatric high grade glioma 5.1
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 5.06
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 5.04
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 5.04
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 5.03
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 5.03
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 5.0
The cohesin release factor WAPL restricts chromatin loop extension. 4.99
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 4.99
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 4.99
Dysregulated immune system networks in war veterans with PTSD 4.95
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 4.94
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 4.94
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.94
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.94
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.91
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 4.9
RNA-Seq in neutrophils from Antiphospholipid Syndrome 4.88
Gene expression profiling of leukemia cells following asparagine depletion 4.88
Expression by CD133+ cells isolated from the adult human exocrine pancreas 4.87
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  4.86
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.85
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.84
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 4.84
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 4.83
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.82
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 4.72
CircRNAome diversity in human mature B-cells, T-cells and monocytes 4.7
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 4.69
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 4.69
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 4.63
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.62
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.6
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 4.59
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 4.54
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.53
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.49
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.49
BCL11B 4.47
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 4.46
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.45
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.41
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 4.41
RNA sequencing of BT142 and TS603 cell lines 4.41
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 4.37
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.35
HNRNPL and its RNA Targets in Prostate Cancer 4.35
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 4.35
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 4.33
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 4.29
RNAseq Study in CC-671 Treated Cal-51 Cells 4.28
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 4.26
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 4.26
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 4.25
Androgen Receptor-regulated genes in prostate cancer cells 4.25
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 4.25
Disruption of the exocyst induces podocyte loss and dysfunction 4.25
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.24
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 4.24
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.23
Transcriptome analysis of U87 cells upon LINC00152 knockdown 4.22
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 4.19
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 4.15
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.15
Transcriptome analysis of peripheral blood monocytes 4.14
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 4.12
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 4.1
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 4.1
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 4.09
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 4.07
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.02
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.02
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 4.02
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 4.0
Region-specific Innate Antiviral Responses of the Human Epididymis 3.97
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 3.95
RNA-sequencing of human liver tissue 3.95
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.93
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 3.92
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.87
Transcriptomes of human monocytes after ex vivo exposure to uric acid 3.86
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 3.81
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 3.73
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 3.73
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 3.72
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 3.72
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.72
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 3.7
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 3.68
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.67
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 3.67
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.66
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.66
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 3.62
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.59
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.58
Intron retention induced by microsatellite expansions as a disease biomarker. 3.57
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.56
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.56
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 3.53
Expression data from miR340 overexpressing human A549 cells 3.51
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 3.49
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 3.41
Generation and persistence of human tissue-resident memory T cells in lung transplantation 3.35
Tpl-2 and MEK small molecule inhibitors 3.32
Tpl-2 small molecule project 3.32
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 3.31
Hypoxic transcriptome of SQ20B human head and neck cancer cells 3.3
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 3.29
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.28
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 3.28
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 3.28
Systematic discovery of endogenous human ribonucleoprotein complexes 3.27
SLIGRL-induced gene expression changes in NHEK cells 3.27
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 3.26
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 3.23
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.22
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.22
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 3.22
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 3.21
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.18
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 3.18
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.17
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.17
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 3.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.15
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.15
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 3.14
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.09
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 3.08
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 3.06
Determination of tRNA aminoacylation levels by high throughput sequencing 3.04
RNA-seq of RKO cells with cTAZ KO or putback 3.04
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.01
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 2.99
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.99
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.96
Differentiation enhances Zika virus infection in neuronal brain cells 2.92
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.91
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 2.91
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.89
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 2.88
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 2.88
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 2.87
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 2.86
Tyrosine Kinase Inhibitor Cardiotoxicity 2.86
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.83
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 2.8
Molecular analysis of renal cell carcinoma with unclassfied histology 2.8
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.79
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 2.78
Transcriptome Profiling of Human Primary Monocytes 2.77
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.75
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.73
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.73
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.72
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.72
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 2.69
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.69
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 2.69
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.68
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 2.66
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.66
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.66
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.64
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.64
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 2.63
Co-regulation of splicing by Rbfox1 and hnRNP M 2.63
MCF-7 as a model for functional analysis of breast cancer risk variants 2.59
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 2.57
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.53
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 2.52
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 2.52
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.51
Dissecting neural differentiation regulatory networks through epigenetic footprinting 2.49
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 2.42
Transcriptome wide analysis of classically and alternatively activated macrophages 2.41
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.4
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.4
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.38
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 2.35
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.33
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 2.32
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 2.3
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.28
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 2.28
CD86 regulates a pro-survival signal in myeloma cells 2.26
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 2.22
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.21
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.19
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 2.19
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.18
FGF2 regulation of gene expression in stable inducible Neurons 2.16
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.14
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.14
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.14
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.13
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 2.11
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 2.1
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 2.1
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.1
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.1
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.1
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.09
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.07
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 2.05
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 2.04
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.04
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.04
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.04
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 2.03
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 2.03
RNA-seq analysis upon ARID1B overexpression 2.02
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.01
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.01
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.98
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.96
Effect of drugs on transcriptomic profiles 1.93
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.92
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 1.92
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 1.92
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.92
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.89
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.84
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.83
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 1.82
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.78
Transcriptome-wide response to synthetic chromatin protein PcTF 1.76
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 1.75
The transcriptome of Kawasaki Disease arteritis 1.74
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 1.7
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.68
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 1.67
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.66
RNA-seq analysis of control and Myc-induced U2OS cells 1.65
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.59
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.58
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.57
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.56
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.56
Novel Targeting of Transcription and Metabolism in Glioblastoma 1.54
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 1.53
Gene expression analysis of human hepatocellular cancers 1.52
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.51
The circadian transcriptional landscape in primary human mammary epithelial cells 1.51
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.49
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 1.49
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 1.48
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.47
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 1.36
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.35
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.35
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 1.34
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 1.3
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.28
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 1.28
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 1.26
Functional significance of the HIV-1 Tat signature amino acid residues 1.25
SF3B1 Degron knockdown RNA-seq 1.24
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.2
High-resolution comparative analysis of great ape genomes 1.18
Discovering human diabetes-risk gene function with genetics and physiological assays 1.17
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.14
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 1.12
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 1.12
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 1.11
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 1.11
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.1
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.08
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.07
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.06
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.06
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 1.04
Mapping interactions for the TNIP2 hub protein 1.03
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.02
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.02
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.01
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.0
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.0
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.99
Changes in human endometrial gland transcriptome over the window of implantation 0.97
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.96
IMP3 regulated gene expression in breast cancer cells 0.96
Human optic chiasm from healthy controls and multiple sclerosis patients 0.93
Multiple sclerosis and EAE 0.93
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.93
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.92
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.91
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 0.91
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.9
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.9
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.89
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.88
Transposon-based construction of strand-specific RNA-seq libraries 0.86
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.74
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.74
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.73
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.69
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.69
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.68
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.68
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.67
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 0.64
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.61
An optimization system for isolating and sequencing of single human colon cancer cells 0.6
RNA-seq data 0.6
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.58
RNA-seq of primary patient AML samples 0.57
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.56
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.55
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 0.47
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.41
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.4
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.4
O-glcnAc reprograms cellular energetics 0.4
Oncogenic roles of ARID5B in T-ALL 0.38
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.38
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.38
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.35
The contribution of Alu exons to the human proteome 0.35
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.34
Reprogrammed myeloid cell transcriptomes in NSCLC 0.33
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.33
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.33
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.31
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.31
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 0.3
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 0.3
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.29
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.27
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.26
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.25
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.25
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.22
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.21
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.19
Expression analysis of the TAF1 syndrome 0.19
Role of FGFR1 in neuronal devlopment 0.18
hNSCs siRNA NOVA2 0.17
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.16
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 0.15
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.15
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.15
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.15
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.13
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.13
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.08
Modulation of nonsense-mediated decay by rapamycin 0.05
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.05
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.04
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.02
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation